Opportunity Overview
The U.S. Food and Drug Administration is seeking 2D High-Density Multi-Electrode Array Electrophysiology Platform, RFQ_CBER-2026-135968, including the complete instrument platform, software, accessories, initial consumables, installation, verification, calibration, training, warranty coverage, and maintenance options.
Deadline
Quotes are due September 23, 2026 at 10:00 AM Eastern Daylight Time. Written questions are due September 17, 2026 at 10:00 AM Eastern Daylight Time.
Scope
The base requirement covers the 2D high-density MEA electrophysiology platform and associated supplies and services, together with a two-year warranty from final Government acceptance. The solicitation also includes three one-year option periods for preventative maintenance and repair services. Quotations must include technical documentation demonstrating compliance with all mandatory minimum requirements, pricing for the base and option periods, warranty information, delivery lead time, country of origin for offered end products, UEI, and confirmation of active SAM.gov registration.
Competition and Evaluation
The procurement is unrestricted under NAICS 334516, Analytical Laboratory Instrument Manufacturing, and PSC 6640, Laboratory Equipment and Supplies. Award will be made using a Lowest Price Technically Acceptable approach. Technical acceptability is evaluated on a pass/fail basis against the solicitation and requirements document, and the acquisition is subject to the Trade Agreements Act.
Funding / Contract Value
No fixed maximum contract value is stated in the public notice.